Biossil is an applied AI drug discovery platform to create specialized treatments for distinct patients.
Biossil has raised $153.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2026.
Biossil's investors include Founders Fund, Quiet Capital, 137 Ventures, Golden Ventures, OpenAI Startup Fund.
Biossil is headquartered in Toronto, Canada.
Biossil is an applied AI drug discovery platform to create specialized treatments for distinct patients.
Biossil is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biossil — Funding & Investors." VCBacked, September 28, 2026, https://www.vcbacked.co/company/biossil. Accessed October 6, 2026.
VCBacked. (2026). Biossil — Funding & Investors. Retrieved October 6, 2026, from https://www.vcbacked.co/company/biossil
{{cite web |title=Biossil — Funding & Investors |url=https://www.vcbacked.co/company/biossil |website=VCBacked |access-date=October 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated